Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 23:15 | 2025-08-13 | LLY | ELI LILLY & Co | Van Naarden Jacob | Officer; EVP & Pres., Lilly Oncology | Pharmaceutical Preparations | BUY | $647.36 | 1,000 | $647,360 | 20,562 | +5.1% |
| 2018-12-13 01:17 | 2018-12-10 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $135.50 | 9,000 | $1,219,514 | 13,700 | -39.6% |
| 2018-11-29 01:13 | 2018-11-26 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $147.97 | 10,000 | $1,479,706 | 13,700 | -42.2% |
| 2018-10-05 23:46 | 2018-10-03 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $165.13 | 10,000 | $1,651,261 | 13,700 | -42.2% |
| 2018-09-15 01:14 | 2018-09-12 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $166.32 | 10,000 | $1,663,179 | 13,700 | -42.2% |
| 2018-08-16 00:27 | 2018-08-13 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $159.34 | 10,000 | $1,593,446 | 13,700 | -42.2% |
| 2018-07-12 00:03 | 2018-07-09 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $183.50 | 3,082 | $565,538 | 13,700 | -18.4% |
| 2018-06-22 00:03 | 2018-06-19 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $178.14 | 3,082 | $549,036 | 12,000 | -20.4% |
| 2018-05-16 23:46 | 2018-05-14 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $137.42 | 3,082 | $423,515 | 0 | -100.0% |
| 2018-04-26 23:32 | 2018-04-24 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $131.23 | 3,082 | $404,461 | 0 | -100.0% |
| 2018-03-16 00:01 | 2018-03-13 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $131.41 | 3,082 | $404,995 | 0 | -100.0% |
| 2018-02-15 01:35 | 2018-02-12 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $96.34 | 3,082 | $296,912 | 0 | -100.0% |
| 2018-01-19 01:02 | 2018-01-16 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $88.21 | 3,082 | $271,867 | 0 | -100.0% |
| 2017-12-19 01:42 | 2017-12-14 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $81.19 | 3,082 | $250,240 | 0 | -100.0% |
| 2017-11-30 01:21 | 2017-11-27 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $74.50 | 3,082 | $229,598 | 0 | -100.0% |
| 2017-11-02 00:06 | 2017-10-30 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $86.89 | 3,082 | $267,789 | 0 | -100.0% |
| 2017-09-21 00:05 | 2017-09-18 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $89.00 | 3,082 | $274,289 | 0 | -100.0% |
| 2017-08-17 00:22 | 2017-08-14 | LOXO | N/A | Van Naarden Jacob | Officer; Chief Business Officer | Other | OPT+S | $73.57 | 3,082 | $226,753 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.